|
Market Closed -
Nasdaq
06:00:00 01/09/26 am AEST
|
5-day change | 1st Jan Change | ||
| 198.52 USD | -0.25% |
|
-3.35% | +8.69% |
| 01/09 | Axsome Therapeutics Initiates SUMMIT Phase 3 Trial Of AXS-05 In Smoking Cessation | CI |
| 31/08 | Axsome Therapeutics Starts Phase 3 Trial of AXS-05 for Smoking Cessation | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Biopharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 10.4B | - | ||||
| 79.79B | |||||
| 58.85B | |||||
| 56.03B | - | ||||
| 51.26B | |||||
| 47.68B |
Select your edition
All financial news and data tailored to specific country editions
